红日药业：补缴税款及滞纳金合计3,383.82万元

Core Viewpoint - Hongri Pharmaceutical (300026.SZ) announced the need to pay back taxes and penalties totaling 33.83 million yuan, which will directly impact the net profit attributable to shareholders in 2025 [1] Group 1 - The company and its wholly-owned subsidiary are required to pay back taxes of 25.166 million yuan and late fees of 8.6722 million yuan, totaling 33.8382 million yuan [1] - The total amount has been fully paid and does not involve any administrative penalties [1] - The payment will be recorded in the 2025 financial results, affecting the net profit for that year [1]